ResMed Announces Participation in the 42nd Annual J.P. Morgan Healthcare Conference
December 27 2023 - 4:05PM
ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief
executive officer and chair of the board, will present at the 42nd
Annual J.P. Morgan Healthcare Conference on Monday, January 8,
2024, beginning at approximately 2:15 p.m. (Pacific Standard Time)
at the Westin St. Francis in San Francisco, CA.
More information about this event, including access to the live,
audio-only webcast, may be accessed by visiting
https://investor.resmed.com. The audio-only webcast replay will be
available approximately 24 hours after the live webcast ends and
will be accessible for the following thirty (30) days.
About ResMedAt ResMed (NYSE: RMD, ASX: RMD) we
pioneer innovative solutions that treat and keep people out of the
hospital, empowering them to live healthier, higher-quality lives.
Our digital health technologies and cloud-connected medical devices
transform care for people with sleep apnea, COPD, and other chronic
diseases. Our comprehensive out-of-hospital software platforms
support the professionals and caregivers who help people stay
healthy in the home or care setting of their choice. By enabling
better care, we improve quality of life, reduce the impact of
chronic disease, and lower costs for consumers and healthcare
systems in more than 140 countries. To learn more, visit
ResMed.com and follow @ResMed.
For
investors |
|
For
media |
+1 858.836.5000 |
|
+1 619.510.1281 |
investorrelations@resmed.com |
|
news@resmed.com |
ResMed (NYSE:RMD)
Historical Stock Chart
From Mar 2024 to Apr 2024
ResMed (NYSE:RMD)
Historical Stock Chart
From Apr 2023 to Apr 2024